Browse > Article
http://dx.doi.org/10.5667/tang.2018.0023

A bioassay system for pharmacological standardization of Withania somnifera derived herbal remedies  

Dey, Amitabha (Neuropharmacology Research Laboratory, Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology (Banaras Hindu University))
Chatterjee, Shyam Sunder (Stettiner Strasse 1)
Kumar, Vikas (Neuropharmacology Research Laboratory, Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology (Banaras Hindu University))
Publication Information
CELLMED / v.9, no.1, 2019 , pp. 1.1-1.13 More about this Journal
Abstract
Background: Contents of bioactive substances extractable from different parts of terrestrial plants vary enormously. Aim: To ascertain that parts of Withania somnifera other than its roots can also be used for prevention and cure of unavoidable stress triggered central hypersensitivity to pain. Material and Methods: Groups of male or female mice treated either with Withania somnifera extracts or with metformin, aspirin, imipramine, diazepam and niacin for 11 consecutive days were subjected to "foot-shock stress-induced hyperthermia" and "hot plate" tests on the 1st, 5th, 7th, and 10th days of the experiments. On the 11th day, they were subjected to tail suspension test and on 12th day pentobarbital hypnosis test. Results: Except for diazepam and imipramine, protective effects of all other tested drugs as well as of the Withania somnifera extracts against stress-induced central hypersensitivity to pain were accompanied by their preventive effects against foot-shock stress-induced body weight losses. All observed stress response suppressing effects of all test agents increased with increasing numbers of treatment days. However, mean duration of pentobarbital-induced sleep was shorter in the extracts treated groups and longer in the diazepam treated ones only. Conclusions: Reported observations reveal that pharmacological activity profile of Withania somnifera extracts in male and female mice are almost identical, and are not like those of several drugs currently often prescribed for the treatment of diabetes-associated comorbidities. Withanolides are not the only extractable bioactive constituents of Withania somnifera. The described bioassay system is well suited for pharmacological standardization of diverse types of Withania somnifera extracts.
Keywords
Withania somnifera; Stress; Hyperalgesia; Depression; Bioassay;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Alam N, Hossain M, Khalil MI, Moniruzzaman M, Sulaiman SA, Gan SH. High catechin concentrations detected in Withania somnifera (ashwagandha) by high performance liquid chromatography analysis. BMC Complement Altern Med 2011:11(1): 65.   DOI
2 Ameh SJ, Toge BK, Ebeshi BU, Ambi AA, Garba M, Alfa J, Gamaniel KS. Herbal Drug Development from Traditional Formulations: Refocusing Pharmaceutics and Posology for Accelerated Validation. Brit J Pharm Res. 2014:4(12):1451-76.   DOI
3 Andrew R, Izzo AA. Principles of pharmacological research of nutraceuticals. Br J Pharmacol. 2017:174(11):1177-94.   DOI
4 Balasubramani SP, Venkatasubramanian P, Kukkupuni SK, Patwardhan B. Plant-based Rasayana drugs from Ayurveda. Chin J Integr Med/ 2011:17(2):88-94.   DOI
5 Berk M, Dean O, Drexhage H, McNeil JJ, Moylan S, O'Neil A, Davey CG, Sanna L, Maes M. Aspirin: a review of its neurobiological properties and therapeutic potential for mental illness. BMC Med. 2013:11:74.   DOI
6 Bharti SK, Bhatia A, Tewari SK, Sidhu OP, Roy R. Application of HR-MAS NMR spectroscopy for studying chemotype variations of Withania somnifera (L.) Dunal. Magn Reson Chem. 2011:49(10): 659-667.   DOI
7 Bhatia A, Bharti SK, Tewari SK, Sidhu OP, Roy R. Metabolic profiling for studying chemotype variations in Withania somnifera (L.) Dunal fruits using GC-MS and NMR spectroscopy. Phytochemistry. 2013:93:105-15.   DOI
8 Can A, Dao DT, Terrillion CE, Piantadosi SC, Bhat S, Gould TD. The tail suspension test. J Vis Exp. 2012:59:3769.
9 Chatterjee S, Srivastava S, Khalid A, Singh N, Sangwan RS, Sidhu OP, Roy R, Khetrapal CL, Tuli, R. Comprehensive metabolic fingerprinting of Withania somnifera leaf and root extracts. Phytochemistry. 2010:71(10):1085-94.   DOI
10 Chatterjee SS, Kumar V. Quantitative Systems Pharmacology: Lessons from Fumaric acid and Herbal Remedies. Drug Designing. 2017:6(152):1-9.
11 Dar NJ, Hamid A, Ahmad M. Pharmacologic overview of Withania somnifera the Indian Ginseng. Cell Mol Life Sci. 2015:72: 4445-60.   DOI
12 Dey A, Chatterjee SS, Kumar V. Analgesic activity of a Withania somnifera extract in stressed mice. Orient Pharm Exp Med. 2016:16(4):295-302.   DOI
13 Dey A, Chatterjee SS, Kumar V. Low dose effects of a Withania somnifera extract on altered marble burying behavior in stressed mice. J Intercult Ethnopharmacol. 2016:5(3): 274-277.   DOI
14 Hankin BL, Abramson LY. Development of gender differences in depression: An elaborated cognitive vulnerability transactional stress theory. Psychol Bull. 2001:127(6): 773-796.   DOI
15 Kaushik MK, Kaul SC, Wadhwa R, Yanagisawa M, Urade Y. Triethylene glycol, an active component of Ashwagandha (Withania somnifera) leaves, is responsible for sleep induction. PLoS One. 2017:12(2):e0172508.   DOI
16 Khan SA, Chatterjee SS, Kumar V. Low dose aspirin like analgesic and anti-inflammatory activities of monohydroxybenzoic acids in stressed rodents. Life Sci. 2016:148:53-62.   DOI
17 Dempsey DA, Klessig DF. How does the multifaceted plant hormone salicylic acid combat disease in plants and are similar mechanisms utilized in humans? BMC Biol. 2017:15(1): 23.   DOI
18 Kumar A, Kaul MK, Bhan MK, Khanna PK, Suri KA. Morphological and chemical variation in 25 collections of the Indian medicinal plant, Withania somnifera (L.) Dunal (Solanaceae). Genet Resour Crop Evol. 2007:54(3) 655-660.   DOI
19 Kumar V, Dey A, Chatterjee SS Phytopharmacology of Ashwagandha as an Anti-Diabetic Herb. In: Science of Ashwagandha: Preventive and Therapeutic Potentials. Kaul SC, Wadhwa R. ed. (Basel, Switzerland: Springer International Publishing), pp.37-68, 2017.
20 Kumar V, Dey A, Hadimani MB, Marcovic T, Emerald M Chemistry and pharmacology of Withania somnifera: An update. TANG [Humanitas Medicine]. 2015:5: e1.
21 Kumar V, Thakur AK, Verma S, Yadav V, Chatterjee SS. Potential of some traditionally used edible plants for prevention and cure of diabesity associated comorbidities. TANG [Humanitas Medicine]. 2015:5(2):8.1-8.22.   DOI
22 Mathur R, Velpandian T Medicinal plant-based health products: Where is the medicinal constituent? Indian J Pharmacol. 2009:41(4):205-206.   DOI
23 Murthy HN, Dijkstra C, Anthony P, White DA, Davey MR, Power JB, Hahn EJ, Paek KY. Establishment of Withania somnifera hairy root cultures for the production of withanolide A. J Integr Plant Biol 2008:50(8):975-81.   DOI
24 Ojima K, Matsumoto K, Tohda M, Watanabe H. Hyperactivity of central noradrenergic and CRF system is involved in social isolation-induced decrease in pentobarbital sleep. Brain Res. 1995:684(1):87-94.   DOI
25 Olff M, Langeland W, Draijer N, Gersons BP. Gender differences in posttraumatic stress disorder. Psychol Bull. 2007:133(2):183-204.   DOI
26 Orru A, Casu MA, Tambaro S, Marchese G, Casu G, Ruiu S. Withania somnifera (L.) Dunal root extract alleviates formalin-induced nociception in mice: involvement of the opioidergic system. Behav Pharmacol. 2016:27(1):57-68.   DOI
27 Pal A, Kumar M, Saharan V, Bhushan B. Antioxidant and free radical scavenging activity of Ashwagandha (Withania somnifera L.) leaves. Journal of Global Biosciences 2015:4(1): 1127-37.
28 Pratibha C, Madhumati B, Akarsh P. Therapeutic Properties and Significance of Different parts of Ashwagandha-A Medicinal Plant. International Journal of Pure & Applied Bioscience. 2013:1(6):94-101.
29 Rahola JG. Somatic drugs for psychiatric diseases: aspirin or simvastatin for depression?. Curr Neuropharmacol. 2012:10(2):139-58.   DOI
30 Rai M, Jogee PS, Agarkar G, dos Santos CA. Anticancer activities of Withania somnifera: Current research, formulations, and future perspectives. Pharm Biol. 2016:54(2):189-97.   DOI
31 Rauniyar BK, Shakya A, Thakur AK, Chatterjee SS, Kumar V. Anti-Stress Activity of Phloroglucinol: A Transient Metabolite of Some Plant Polyphenolics. Pharmacologia. 2015:6:21-30.   DOI
32 Rayees S, Malik F. Withania somnifera: From Traditional Use to Evidence Based Medicinal Prominence. In: Science of Ashwagandha: Preventive and Therapeutic Potentials. Kaul SC, Wadhwa R. ed. (Basel, Switzerland: Springer International Publishing), pp.81-103, 2017.
33 Sangwan RS, Chaurasiya ND, Misra LN, Lal P, Uniyal GC, Sharma R, Sangwan NS, Suri KA, Qazi GN and Tuli R. Phytochemical variability in commercial herbal products and preparations of Withania somnifera (Ashwagandha). Curr Sci. 2004:86(3):461-465.
34 Shrivastava N, Dey A, Chatterjee SS, Kumar V. Adaptogenic Potential of Triethylene Glycol and Quercetin in Stressed Mice. Pharm Pharmacol Int J. 2015:2(6):197-206
35 Singh B, Chandan BK, Gupta DK. Adaptogenic activity of a novel withanolide-free aqueous fraction from the roots of Withania somnifera Dun. (Part II). Phytother Res. 2003:17: 531-536.   DOI
36 Singh B, Saxena AK, Chandan BK, Gupta DK, Bhutani KK, Anand KK. Adaptogenic activity of a novel, withanolide-free aqueous fraction from the roots of Withania somnifera Dun. Phytother Res. 2001:15:311-318.   DOI
37 Singh N, Bhalla M, de Jager P, Gilca M. Ashwagandha, An overview on ashwagandha: a Rasayana (rejuvenator) of Ayurveda. Afr J Tradit Complement Altern Med. 2011:8(5 Suppl):208-13.
38 Thakur AK, Dey A, Chatterjee SS, Kumar V. Reverse Ayurvedic pharmacology of Ashwagandha as an adaptogenic anti-diabetic plant: a pilot study. Curr Trad Med. 2015:1:51-61.   DOI
39 Turner RA. Analgesics. In Screening methods in pharmacology. (New York, USA: Academic Press), pp.100-102, 1965
40 Virk JK, Bansal P, Gupta V, Kumar S, Singh R. Lack of pharmacological basis of substitution of an endangered plant group Ashtawarga-A significant ingredient of polyherbal formulations. American Journal of Phytomedicine and Clinical Therapeutics. 2015:2:690-712.
41 Virk JK, Gupta V, Kumar S, Singh R, Bansal P. Ashtawarga plants-Suffering a triple standardization syndrome. J Tradit Complement Med. 2017:7(4):392-99.   DOI
42 Wadhwa R, Singh R, Gao R, Shah N, Widodo N, Nakamoto T, Ishida Y, Terao K, Kaul SC. Water extract of Ashwagandha leaves has anticancer activity: identification of an active component and its mechanism of action. PLoS One. 2013:8(10):e77189.   DOI
43 Winston D, Maimes S. Adaptogens: Herbs for Strength, Stamina, and Stress Relief. (Vermont, USA : Inner Traditions-Bear & Co.), 2007.
44 Yunus MB. Fibromyalgia and overlapping disorders: the unifying concept of central sensitivity syndromes. Semin Arthritis Rheum. 2007;36(6): 339-356. doi:10.1016/j.semarthrit.2006.12.009.   DOI
45 Yunus MB. Thematic issue: an update on central sensitivity syndromes and the issues of nosology and psychobiology. Curr Rheumatol Rev. 2015;11(2): 70-85.   DOI
46 Zhou J, Chan L, Zhou S. Trigonelline: a plant alkaloid with therapeutic potential for diabetes and central nervous system disease. Curr Med Chem 2012;19(21): 3523-31.   DOI